1. Home

Latest news

LIRH Annual Conference: Towards the Cure of Huntington Disease - December 3, 2021

SOM3355: a new drug for the treatment of the "chorea" symptom in Huntington's disease

Huntington's and Suicide - 10 September: World Suicide Prevention Day

International confirmation of the number of HD affected in Italy (LIRH estimate)

The mind fragility of Huntington Disease patients in a recent publication

Rare Barometer 2021: patients opinion on the future of rare diseases

Huntington Disease and Yoga: online classes for caregivers

Rare Diseases and Huntington's Disease: Patients' Appeal to Policy Makers

Buone notizie da UniQure sulla sperimentazione con ATM-130 per la malattia di Huntington

Huntington's disease: Tominersen dosing interruption in Generation HD1 - Questions and Answers

Si interrompe la somministrazione di tominersen nella sperimentazione Generation HD1 di Roche per la malattia di Huntington

Huntington Disease (HD): Let’s color our voices! - Rare Disease Day 2021

Updates on AMT-130 gene therapy for the treatment of Huntington's disease

A common neurodegeneration marker for Huntington's, Parkinson's, and Alzheimer's disease

The first European patients in the Phase 3 'Proof-HD' trial with Pridopidine in Huntington's disease are from Italy and Germany

Healthe-RND: Toward a telemedicine model for Huntington's and rare neurodegenerative diseases

LIRH Annual Conference 2020: The Current treatment Perspectives for Huntington Disease

World (dis)ability Day 2020

PTC Therapeutics has started in-human Huntington’s disease trial with PTC518

The emotions' recognition and the adequacy of visual scanning in a recent study on pre-manifest HD

Huntington’s Disease: Prilenia Enrolls First Patients into PROOF-HD Clinical Trial

Treatment for SMA could be used for Huntington’s disease: new trial planned for next year

Huntington Disease: other two Patients Treated in the AMT-130 Trial